Your browser doesn't support javascript.
loading
Factors associated with adherence and viral suppression among patients on second-line antiretroviral therapy in an urban HIV program in Kenya.
Nyaboke, Rose; Ramadhani, Habib Omari; Lascko, Taylor; Awuor, Patrick; Kirui, Elvis; Koech, Emily; Mutisya, Immaculate; Ngunu, Carol; Wangusi, Rebecca.
Afiliação
  • Nyaboke R; CIHEB Kenya, Nairobi, Kenya.
  • Ramadhani HO; IHV, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Lascko T; IHV, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Awuor P; CIHEB Kenya, Nairobi, Kenya.
  • Kirui E; Amref Health Africa, Nairobi, Kenya.
  • Koech E; CIHEB Kenya, Nairobi, Kenya.
  • Mutisya I; CDC Kenya, Division of Global HIV & TB (DGHT), US Centers for Disease Control and Prevention (CDC), Nairobi, Kenya.
  • Ngunu C; Nairobi County-MOH, Nairobi Metropolitan Services, Nairobi, Kenya.
  • Wangusi R; CIHEB Kenya, Nairobi, Kenya.
SAGE Open Med ; 11: 20503121231162354, 2023.
Article em En | MEDLINE | ID: mdl-37008685
ABSTRACT

Objective:

The aim of this study is to estimate the proportion of virologically suppressed People living with HIV on second-line ART and to identify factors associated with virologic suppression. With an increasing population of patients on complex second-line anti retroviral therapy (ART), understanding the factors associated with viral suppression and adherence is critical for ensured longevity of ART.

Methods:

A retrospective study was conducted of patients on second-line ART in 17 facilities supported by University of Maryland, Baltimore, in Nairobi, Kenya, covering the period beginning October 2016 up to August 2019. Viral suppression was defined as viral load <1000 copies/mL in a test conducted in the last 12 months. Adherence was assessed through self-reports and classified as optimal (good) or suboptimal (inadequate/poor). Associations were presented as adjusted risk ratios with 95% confidence intervals. Statistical significance was considered when p value ⩽0.05.

Results:

Of 1100 study participants with viral load data, 974 (88.5%) reported optimal adherence while on first-line ART and 1029 (93.5%) reported optimal adherence to second-line ART. Overall, viral load suppression on second-line ART was 90%. Optimal adherence ((adjusted risk ratio) 1.26; 95% confidence interval 1.09-1.46)) and age 35-44 versus 15-24 years ((adjusted risk ratio) 1.06; 95% confidence interval 1.01-1.13)) were associated with viral suppression . Adherence to first-line ART ((adjusted risk ratio) 1.19; 95% confidence interval 1.02-1.40)) was associated with adherence to second-line ART.

Conclusion:

Viral suppression remains high and adherence was strongly associated with viral suppression, underscoring the need to adequately address the barriers to adherence before switching regimens.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: SAGE Open Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: SAGE Open Med Ano de publicação: 2023 Tipo de documento: Article